表紙
市場調查報告書

按藥物類型,最終用途,用途和用途劃分的全球BCG疫苗市場:對COVID-19潛在影響的見解和預測(2020-2024)

Global BCG Vaccine Market (By Drug Type, End Use, Usage & Application): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

出版商 Koncept Analytics 商品編碼 941643
出版日期 內容資訊 英文 97 Pages
訂單完成後即時交付
價格
按藥物類型,最終用途,用途和用途劃分的全球BCG疫苗市場:對COVID-19潛在影響的見解和預測(2020-2024) Global BCG Vaccine Market (By Drug Type, End Use, Usage & Application): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
出版日期: 2020年06月11日內容資訊: 英文 97 Pages
簡介

在2020年至2024年的預測期內,全球BCG疫苗市場預計將以4.7%的複合年增長率增長,到2024年將達到6553萬美元。市場上的主要增長因素是:結核病患病率增加,結核病研究與開發經費增加,膀胱癌的發病率增加,廣泛耐藥結核病的患病率增加以及卡介苗接種疫苗的覆蓋率增加。

本報告調查了全球BCG疫苗市場,包括市場增長因素,市場趨勢,挑戰,COVID-19影響,按藥物類型,最終用戶,用途,用途和地區以及競爭進行的市場分析。我們提供有關主要公司的狀況和概況的信息。

內容

第1章市場概述

  • 卡介苗疫苗
  • 醫療用途:肺結核
  • 醫療:癌症
  • 醫療:分枝桿菌
  • 卡介苗的給藥方法
  • 卡介苗的負面影響
  • 卡介苗預防措施
  • 卡介苗的副作用

第2章COVID-19的影響

  • 對世界經濟的影響
  • 自然流量的變化
  • COVID-19的世界時尚

第3章市場分析

  • 按銷售量:全球市場
  • 按銷售量:全球市場預測
  • 按藥物類型
  • 按最終用戶
  • 通過使用
  • 通過申請
  • 按地區

第4章區域市場

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第5章市場動態

  • 生長因子
    • 結核病迅速增加
    • 增加結核病研發資金
    • 膀胱癌的發病率增加
    • 美國用於結核病的資金激增
    • 廣泛耐藥結核的患病率增加
    • 擴大卡介苗接種範圍
  • 主要趨勢/進展
    • 降低目標結核病發病率
    • 降低了結核病的目標死亡率
  • 挑戰
    • BCG對成人的影響有限

第6章競爭情況

  • 世界市場
    • 收入比較:主要公司
    • 市值比較:主要公司
    • 研發成本比較:主要公司
    • 全球市場份額比較:主要公司

第7章公司簡介

  • Merck & Co.
  • Sanofi (Sanofi Pasteur)
  • Statens Serum Institut
  • China National Biotec Group (China National Pharmaceutical Group)
  • Serum Institute of India Pvt. Ltd. (SII)
  • Green Signal Bio Pharma Ltd.
目錄

The global BCG vaccine market is anticipated to reach US$65.53 million in 2024, growing at a CAGR of 4.70% during the period spanning 2020-2024. Growth in the global BCG vaccine market was driven by factors like increasing prevalence of tuberculosis, rising R&D funding on tuberculosis, growing incidences of bladder cancer, increasing prevalence of extensively drug resistant tuberculosis and surging BCG immunization coverage. The key trends that are expected to be faced by the market are declining targeted incidence rate of tuberculosis and decreasing targeted mortality of tuberculosis. The limited impact of BCG vaccine on adults is expected to impose a challenge on the global BCG vaccine market.

The global BCG vaccine market by drug type can be segmented as follows: immune BCG and therapy BCG. In 2019, the higher share of the market was held by immune BCG. The global BCG vaccine by end user can be segmented into the following pediatrics and adults. The dominant share of the market in 2019 was held by pediatrics. The market by usage can be divided into the following segments: tuberculosis and bladder cancer. The largest share of the market was obtained by tuberculosis in 2019. The global BCG vaccine market by application can be segmented as follows: hospitals and clinics, with hospitals holding a greater share of the market in 2019.

The global BCG vaccine market by region can be segmented into the following regions: North America, Europe and Asia Pacific. In 2019, the dominant share of the market was held by North America, followed by Europe and Asia Pacific. North America is predicted to dominate the market during the period spanning 2020-2024, supported by growing tobacco consumption and increasing technological advancements in BCG vaccination.

Scope of the report:

The report provides a comprehensive analysis of the global BCG vaccine market with potential impact of COVID-19.

The major regional markets (North America, Europe and Asia Pacific) have been analyzed.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Merck & Co., Sanofi, Statens Serum Institut, China National Biotec Group (CNBG), Serum Institute of India Pvt. Ltd., Green Signal Bio Pharma Ltd) are also presented in detail.

Key Target Audience:

  • BCG Vaccine Providers/Hospitals
  • API Suppliers
  • End Users (Businesses/Consumers)
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1. BCG Vaccine
  • 1.2. Medical Use: Tuberculosis
  • 1.3. Medical Use: Cancer
  • 1.4. Medical Use: Mycobacteria
  • 1.5. Methods of Administration of BCG
  • 1.6. Adverse Effects of BCG
  • 1.7. Precautions to be taken in BCG
  • 1.8. Side Effects of BCG

2. Impact of COVID-19

  • 2.1. Impact on Global Economy
  • 2.2. Change in Organic Traffic
  • 2.3. Global Prevalence of COVID-19

3. Market Analysis

  • 3.1. Global BCG Vaccine Market by Value
  • 3.2. Global BCG Vaccine Market Forecast by Value
  • 3.3. Global BCG Vaccine Market by Drug Type
    • 3.3.1. Global Immune BCG Market by Value
    • 3.3.2. Global Immune BCG Market Forecast by Value
    • 3.3.3. Global Therapy BCG Market by Value
    • 3.3.4. Global Therapy BCG Market Forecast by Value
  • 3.4. Global BCG Vaccine Market by End User
    • 3.4.1. Global Pediatric BCG Vaccine Market by Value
    • 3.4.2. Global Pediatric BCG Vaccine Market Forecast by Value
    • 3.4.3. Global Adult BCG Vaccine Market by Value
    • 3.4.4. Global Adult BCG Vaccine Market Forecast by Value
  • 3.5. Global BCG Vaccine Market by Usage
    • 3.5.1. Global Tuberculosis BCG Vaccine Market by Value
    • 3.5.2. Global Tuberculosis BCG Vaccine Market Forecast by Value
    • 3.5.3. Global Bladder Cancer BCG Vaccine Market by Value
    • 3.5.4. Global Bladder Cancer BCG Vaccine Market Forecast by Value
  • 3.6. Global BCG Vaccine Market by Application
    • 3.6.1. Global Hospital BCG Vaccine Market Forecast by Value
    • 3.6.2. Global Clinic BCG Vaccine Market Forecast by Value
  • 3.7. Global BCG Vaccine Market by Region

4. Regional Market

  • 4.1. North America
    • 4.1.1. North America BCG Vaccine Market by Value
    • 4.1.2. North America BCG Vaccine Market Forecast by Value
  • 4.2. Europe
    • 4.2.1. Europe BCG Vaccine Market by Value
    • 4.2.2. Europe BCG Vaccine Market Forecast by Value
  • 4.3. Asia Pacific
    • 4.3.1. Asia Pacific BCG Vaccine Market by Value
    • 4.3.2. Asia Pacific BCG Vaccine Market Forecast by Value
  • 4.4. ROW
    • 4.4.1. ROW BCG Vaccine Market by Value
    • 4.4.2. ROW BCG Vaccine Market Forecast by Value

5. Market Dynamics

  • 5.1. Growth Drivers
    • 5.1.1. Surging Prevalence of Tuberculosis
    • 5.1.2. Increasing Research & Development Funding on Tuberculosis
    • 5.1.3. Rising Incidence of Bladder Cancer
    • 5.1.4. Upsurge in the US Funding for Tuberculosis
    • 5.1.5. Rising Prevalence of Extensively Drug-Resistant Tuberculosis
    • 5.1.6. Increasing BCG Immunization Coverage
  • 5.2. Key Trends & Developments
    • 5.2.1. Declining Targeted Incidence Rate of Tuberculosis
    • 5.2.2. Decreasing Targeted Mortality of Tuberculosis
  • 5.3. Challenges
    • 5.3.1. Limited Impact of BCG on Adults

6. Competitive Landscape

  • 6.1. Global Market
    • 6.1.1. Revenue Comparison- Key Players
    • 6.1.2. Market Capitalization Comparison- Key Players
    • 6.1.3. Research & Development Expenses Comparison - Key Players
    • 6.1.4. Global BCG Market Share Comparison - Key Players

7. Company Profiles

  • 7.1. Merck & Co.
    • 7.1.1. Business Overview
    • 7.1.2. Financial Overview
    • 7.1.3. Business Strategies
  • 7.2. Sanofi (Sanofi Pasteur)
    • 7.2.1. Business Overview
    • 7.2.2. Financial Overview
    • 7.2.3. Business Strategies
  • 7.3. Statens Serum Institut
    • 7.3.1. Business Overview
    • 7.3.2. Business Strategies
  • 7.4. China National Biotec Group (China National Pharmaceutical Group)
    • 7.4.1. Business Overview
    • 7.4.2. Business Strategies
  • 7.5. Serum Institute of India Pvt. Ltd. (SII)
    • 7.5.1. Business Overview
    • 7.5.2. Business Strategies
  • 7.6. Green Signal Bio Pharma Ltd.
    • 7.6.1. Business Overview
    • 7.6.2. Business Strategies

List of Charts

  • Medical Uses of BCG Vaccine
  • Medical Use of BCG: Mycobacteria
  • Medical Use of BCG: Mycobacteria
  • Side Effects of BCG
  • Organic Traffic Growth or Decline due to COVID-19 (2020)
  • Global COVID-19 Infected Cases (Jan'20 - May'20)
  • Global BCG Vaccine Market by Value (2015-2019)
  • Global BCG Vaccine Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by Drug Type (2019)
  • Global Immune BCG Market by Value (2015-2019)
  • Global Immune BCG Market Forecast by Value (2020-2024)
  • Global Therapy BCG Market by Value (2015-2019)
  • Global Therapy BCG Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by End User (2019)
  • Global Pediatric BCG Vaccine Market by Value (2015-2019)
  • Global Pediatric BCG Vaccine Market Forecast by Value (2020-2024)
  • Global Adult BCG Vaccine Market by Value (2015-2019)
  • Global Adult BCG Vaccine Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by Usage (2019)
  • Global Tuberculosis BCG Vaccine Market by Value (2015-2019)
  • Global Tuberculosis BCG Vaccine Market Forecast by Value (2020-2024)
  • Global Bladder Cancer BCG Vaccine Market by Value (2015-2019)
  • Global Bladder Cancer BCG Vaccine Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by Application (2019)
  • Global Hospital BCG Vaccine Market Forecast by Value (2019-2024)
  • Global Clinic BCG Vaccine Market Forecast by Value (2019-2024)
  • Global BCG Vaccine Market by Region (2019)
  • North America BCG Vaccine Market by Value (2015-2019)
  • North America BCG Vaccine Market Forecast by Value (2020-2024)
  • Europe BCG Vaccine Market by Value (2015-2019)
  • Europe BCG Vaccine Market Forecast by Value (2020-2024)
  • Asia Pacific BCG Vaccine Market by Value (2015-2019)
  • Asia Pacific BCG Vaccine Market Forecast by Value (2020-2024)
  • ROW BCG Vaccine Market by Value (2015-2019)
  • ROW BCG Vaccine Market Forecast by Value (2020-2024)
  • Global Prevalence of Tuberculosis (2014-2019)
  • Global TB Research & Development Funding (2013-2019)
  • Global Incidence of Bladder Cancer (2014-2019)
  • The US Funding for Global Tuberculosis (2014-2020)
  • Global Prevalence of Extensively Drug-Resistant Tuberculosis (2014-2019)
  • Global BCG Immunization Coverage Rate (2014-2019)
  • Global Targeted Incidence Rate of Tuberculosis (2015-2035)
  • Global Targeted Mortality of Tuberculosis (2015-2035)
  • Key Players - Revenue Comparison (2019)
  • Key Players - Market Capitalization Comparison (2020)
  • Key Players - R&D Expenses Comparison (2019)
  • Key Players - Global BCG Market Share Comparison (2019)
  • Merck & Co. Sales & Net Income (2015-2019)
  • Merck & Co. Sales by Segment (2019)
  • Merck & Co. Sales by Region (2019)
  • Sanofi Net Sales & Net Income (2015-2019)
  • Sanofi Net Sales by Segment (2019)
  • Sanofi Net Sales by Region (2019)